Weiler S, Carson W, Lee Y, Teplow D B, Kishimoto Y, O'Brien J S, Barranger J A, Tomich J M
Department of Pediatrics, University of Southern California, School of Medicine, Childrens Hospital, Los Angeles.
J Mol Neurosci. 1993 Fall;4(3):161-72. doi: 10.1007/BF02782499.
The sphingolipid activator protein, saposin C (also termed SAP 2), was chemically synthesized, purified, and characterized. The fully protected 82-residue protein was synthesized by automated solid-phase methods, with multiple recoupling steps resulting in a high average coupling efficiency of 98.8%. The overall yield was estimated to be approx 40%. Deprotection and cleavage of the peptide from the resin was followed by folding in the absence of chaotropic agents at pH 8.5. The protein was purified by reversed-phase high pressure liquid chromatography (HPLC) and its purity determined by capillary electrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The composition of the synthetic saposin C was determined by amino acid analysis. Its sequence was verified by Edman sequence analysis of overlapping peptide fragments generated by chymotryptic and Staphylococcus aureus V8 digestions. The sequence at the C-terminus was determined by digestion with carboxypeptidase P, followed by phenylthiohydantoin (PTH) derivitization and HPLC analysis of the released amino acid residues. Deglycosylated native saposin C appeared as a lower molecular-weight species than synthetic saposin C on SDS-PAGE. This has been explained by amino acid and C-terminal analysis showing native saposin C to be two amino acids shorter at the C terminus than a deduced sequence (from cDNA) previously published. Synthetic saposin C displayed 85% of full biological activity as determined by its ability to stimulate glucocerebrosidase activity in vitro: Synthetic and native saposin C increased glucocerebrosidase catalyzed hydrolysis of 4-methylumbelliferyl beta-D-glucoside by factors of 6.0 and 7.1, respectively. Furthermore, synthetic and native saposin C share similar K(act) values (0.5 and 1.5 microM respectively) indicating that they bind to glucocerebrosidase with similar affinities.
鞘脂激活蛋白,即鞘脂激活蛋白C(也称为SAP 2),经过化学合成、纯化和特性鉴定。通过自动化固相方法合成了具有82个残基的完全保护型蛋白,经过多次重偶联步骤,平均偶联效率高达98.8%。总产率估计约为40%。从树脂上脱保护并裂解肽后,在pH 8.5且不存在离液剂的情况下进行折叠。通过反相高压液相色谱(HPLC)对该蛋白进行纯化,并通过毛细管电泳和十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)测定其纯度。通过氨基酸分析确定合成的鞘脂激活蛋白C的组成。通过对胰凝乳蛋白酶和金黄色葡萄球菌V8消化产生的重叠肽片段进行埃德曼序列分析来验证其序列。通过用羧肽酶P消化,然后对释放的氨基酸残基进行苯硫代乙内酰脲(PTH)衍生化和HPLC分析来确定C末端的序列。在SDS-PAGE上,去糖基化的天然鞘脂激活蛋白C比合成的鞘脂激活蛋白C呈现出分子量更低的条带。氨基酸和C末端分析表明,天然鞘脂激活蛋白C的C末端比先前发表的推导序列(来自cDNA)短两个氨基酸,这解释了上述现象。通过其在体外刺激葡糖脑苷脂酶活性的能力测定,合成的鞘脂激活蛋白C显示出85%的完全生物学活性:合成的和天然的鞘脂激活蛋白C分别使葡糖脑苷脂酶催化的4-甲基伞形酮基β-D-葡萄糖苷水解增加了6.0倍和7.1倍。此外,合成的和天然的鞘脂激活蛋白C具有相似的K(act)值(分别为0.5和1.5 microM),表明它们以相似的亲和力与葡糖脑苷脂酶结合。